← Leaderboards
Joel Bruggen
Wake Forest University Health Sciences
$13,969
Attributed
$13,969
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $11.4K · FY2005–07$20K$15K$10K$5K$0
'05
'06
'07
Funding mix
By agency
NIH$13,969 · 3
By mechanism
M01$13,969 · 3
Top collaborators
No co-investigators on record.
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Suzanne Craft$45,089,134
- Mark Andrew Espeland$64,414,527
- Paul Laurienti$11,487,813
- Jeff Douglas Williamson$16,761,474
- Denise Kathryn Houston$14,008,246
Others in their field
Top investigators on “Adenomatous Polyps”
- John Anthony Baron · Dartmouth College$19,709,766
- Vadim Backman · Northwestern University$12,057,031
- Michael P Snyder · Yale University$7,375,099
- Anne M McTiernan · Fred Hutchinson Cancer Research Center$6,569,329
- Randall Walter Burt · University Of Utah$6,543,691
- Kenneth W. Kinzler · Johns Hopkins University$6,340,917
Research focus
Adenomatous PolypsAge-YearsCalciumColonoscopyColorectal AdenomaComputer Retrieval Of Information On Scientific Projects DatabaseDiagnosisDoseDouble-Blind MethodFundingGrantInstitutionLarge IntestinePiroxicamPlacebo ControlPreventProspectiveRandomizedRecurrenceResearch PersonnelResourcesSourceSupplementationSurrogate Endpoint
Grant awards (3)
RANDOMIZED, DOUBLE-BLIND, PROSPECTIVE, PLACEBO-CONTROLLED COMPARISON OF CALCIUM$1,324
M01 · FY2007 · RR · contact PI
RANDOMIZED, DOUBLE-BLIND, PROSPECTIVE, PLACEBO-CONTROLLED COMPARISON OF CALCIUM$11,376
M01 · FY2006 · RR · contact PI
PREVENTION OF SPORADIC COLORECTAL ADENOMAS WITH CELECOXIB$1,269
M01 · FY2005 · RR